CT With or Without Contrast for Hematoma
For suspected hematoma, perform CT angiography (CTA) with contrast as the initial imaging study, as it provides superior detection of active bleeding and vascular sources while simultaneously localizing the hematoma—reserve noncontrast CT only for patients with renal dysfunction or when additional contrast load before angiography is a concern.
Clinical Decision Algorithm
Primary Approach: CTA (CT with Contrast)
CTA is the preferred initial imaging modality because it detects active bleeding at rates as low as 0.3 mL/min—significantly more sensitive than conventional angiography (which requires 0.5-1.0 mL/min) 1. In acute bleeding evaluation, CTA identifies active contrast extravasation in 78.9-84.2% of cases, with a sensitivity of 59.5% for detecting active bleeding 1.
Key advantages of CTA:
- Localizes exact hematoma location
- Identifies bleeding source and vascular abnormalities
- Detects the "spot sign"—a validated marker for hematoma expansion 2, 3
- Provides preoperative vascular mapping if intervention needed
- Enables rapid triage to angiography with embolization if indicated
When to Use Noncontrast CT Instead
Noncontrast CT is appropriate only in specific circumstances 1:
- Compromised renal function where contrast poses significant risk
- Anticipated need for immediate angiography where additional contrast load is concerning
- Follow-up imaging to assess hematoma size changes or complications (infection, abscess)
- Chronic hematoma evaluation where active bleeding is not suspected
Noncontrast CT capabilities:
- Confirms or excludes bleeding presence rapidly
- Determines hematoma acuity by attenuation (high/mixed = acute-subacute; low = chronic)
- Identifies sentinel clot suggesting bleeding site
- Evaluates mass effect and complications
Location-Specific Considerations
Retroperitoneal Hematoma
For retroperitoneal bleeding specifically, CTA is appropriate for initial evaluation with the benefit of detecting active bleeding and guiding potential transcatheter arterial embolization 1. The speed and large-area coverage make it ideal for localizing bleeding and identifying causes (groin access, pelvic fracture, mass).
Intracranial Hematoma
For intracerebral hemorrhage, CTA immediately after noncontrast CT diagnosis provides critical benefits 3:
- Early diagnosis of secondary ICH (sensitivity 95.7%)
- Prediction of hematoma growth via spot sign detection
- Minimal AKI risk (odds ratio 1.16, not statistically significant)
The spot sign on CTA significantly improves prediction models for hematoma expansion (AUC 0.787 vs 0.697 without spot sign, p=0.0002) 3.
Subdural Hematoma
Noncontrast CT is the accepted standard for initial evaluation of suspected subdural hematoma due to widespread availability and rapid acquisition 4. However, contrast may help diagnose isodense subdural hematomas 5.
Common Pitfalls to Avoid
- Don't skip contrast in acute bleeding scenarios unless contraindicated—the superior sensitivity for active bleeding detection directly impacts mortality through earlier intervention
- Don't assume noncontrast is sufficient for surgical planning—vascular anatomy and active extravasation guide intervention strategy
- Don't delay imaging for contrast concerns in hemodynamically unstable patients—the diagnostic benefit outweighs theoretical risks in most cases
- Recognize intermittent bleeding reduces CTA sensitivity—negative CTA doesn't exclude bleeding if clinical suspicion remains high
Radiation Considerations
While noncontrast scans contribute substantially to radiation exposure (mean DLP ~928 mGycm vs arterial phase ~631 mGycm) 6, the diagnostic yield of contrast-enhanced imaging justifies the exposure in acute bleeding evaluation. In one study, noncontrast scans were helpful in only 5.2% of acute bleeding cases 6, though this primarily applied to GI bleeding rather than closed-space hematomas where mass effect matters.